BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1648625)

  • 1. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart.
    Lachnit WG; Phillips M; Gayman KJ; Pessah IN
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1205-13. PubMed ID: 8092287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]-nitrendipine binding sites in normal and cardiomyopathic hamsters: absence of a selective increase in putative calcium channels in cardiomyopathic hearts.
    Howlett SE; Rafuse VF; Gordon T
    Cardiovasc Res; 1988 Nov; 22(11):840-6. PubMed ID: 2855722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters.
    Sen LY; O'Neill M; Marsh JD; Smith TW
    Circ Res; 1990 Sep; 67(3):599-608. PubMed ID: 1697792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-nitrendipine binding in normal and cardiomyopathic hamster hearts: modulation by temperature, verapamil and diltiazem.
    Howlett SE; Gordon T
    J Mol Cell Cardiol; 1990 Sep; 22(9):975-85. PubMed ID: 2177794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes.
    Kamp TJ; Sanguinetti MC; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts.
    Sen L; Smith TW
    Circ Res; 1994 Jul; 75(1):149-55. PubMed ID: 8013073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of the cardiac 1,4-dihydropyridine receptor/calcium channel complex.
    Rengasamy A; Ptasienski J; Hosey MM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):1-7. PubMed ID: 2982362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced calcium sensitivity of dihydropyridine binding to calcium channels in spontaneously hypertensive rats.
    Ebata H; Natsume T; Mitsuhashi T; Yaginuma T
    Hypertension; 1991 Feb; 17(2):234-41. PubMed ID: 1846842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of cryptosin with mammalian cardiac dihydropyridine-specific calcium channels.
    Rao VR; Banning JW
    Life Sci; 1990; 47(18):1667-76. PubMed ID: 2174493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine receptors are primarily functional L-type calcium channels in rabbit ventricular myocytes.
    Lew WY; Hryshko LV; Bers DM
    Circ Res; 1991 Oct; 69(4):1139-45. PubMed ID: 1657438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
    Gu XH; Dillon JS; Nayler WG
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues.
    Wagner JA; Weisman HF; Snowman AM; Reynolds IJ; Weisfeldt ML; Snyder SH
    Circ Res; 1989 Jul; 65(1):205-14. PubMed ID: 2544319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.